Supporting this hypothesis, a recent study has revealed that PAX2 negatively regulates the expression of a well-established pro-invasion and pro-metastastic gene, ERBB2 [5,6], in estradiol-treated luminal breast cancer cell lines [17]. The gene discussed is PAX2; the disease is breast carcinoma.